01NICHE-2试验在2024年欧洲肿瘤内科学会 (ESMO)年会上报告了非转移性晚期错配修复功能缺陷 (dMMR)结肠癌患者的新辅助治疗结果，3年无病生存率达100%。

In apparent speculation over the direction of the monetary policy as the Monetary Policy Committee, MPC of the Central Bank ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

Nearly all the cases are in Hennepin County, and MPR News reports that most are among unvaccinated ... Prior to 2020 those ...

A new KARE 11-MPR News-Minnesota Star Tribune Minnesota Poll shows the Democratic ticket with a five-point lead for Minnesota ...

Information about the poll methodology, demographics of the respondents and a map of the geographic regions for this week’s Star Tribune/MPR News/KARE 11 Minnesota Poll.

While neoadjuvant therapy in stage III or great melanoma is already the standard of care, new research presented at ESMO ...

92.1% to 95.8% underwent surgery, 89.7% to 96.2% had R0 surgical outcomes, and 74.1% to 83.6% started adjuvant therapy. The data showed that 65% of 60 evaluable patients achieved pCR/mPR with ...

The FDA has approved Rybrevant in combination with carboplatin and pemetrexed for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer ...

Favorability ratings were essentially even for Walz in a new KARE 11-MPR News-Minnesota Star Tribune Minnesota Poll.

欢迎关注凯莱英药闻由国际肺癌研究协会（IASLC）举办的2024年世界肺癌大会（WCLC）于当地时间9月7-10日在美国圣迭戈举行。WCLC是致力于肺癌和其他胸部恶性肿瘤的多学科肿瘤学会议，每届都有来自全球100多个国家的7000多名专业人士参会，旨 ...

据悉，相关研究数据已先于9月8日在2024世界肺癌大会 (WCLC) ...